Literature DB >> 14722675

Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma.

Tove Grönroos1, Lise Bentzen, Päivi Marjamäki, Rumi Murata, Michael R Horsman, Susanne Keiding, Olli Eskola, Merja Haaparanta, Heikki Minn, Olof Solin.   

Abstract

The first aim of this study was to compare the hypoxia imaging ability of fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) with that of fluorine-18 fluoromisonimidazole ([18F]FMISO) in murine tumours of different sizes under two different oxygenation conditions. Secondly, we wanted to assess the biodistribution of the markers in normal tissues under similar conditions. Female CDF1 mice with a C3H mammary carcinoma grown on their backs were used. Tumours were size matched and animals breathed either normal air (21% O(2)) or carbogen gas (95% O(2) + 5% CO(2)). The gassing procedure was begun 5 min before the intravenous injection of either [18F]FETNIM or [18F]FMISO and continued until the mice were sacrificed at 120 min. Blood, tumour, muscle, heart, lung, liver, kidney and fat were removed, counted for radioactivity and weighed. The tumour and muscle were frozen and cut with a cryomicrotome into sections. The spatial distribution of radioactivity from the tissue sections was determined with digital autoradiography. Estimation of the necrotic fraction was made on sections from formalin-fixed tumours. Digital autoradiography showed that the whole tumour-to-muscle radioactivity uptake ratios were significantly higher in normal air-breathing mice than in carbogen-treated mice for both [18F]FETNIM (4.9+/-2.6 vs 1.8+/-0.5; P<0.01) and [18F]FMISO (4.4+/-1.0 vs 1.5+/-0.4; P<0.01). The carbogen treatment had only slight effects on the biodistribution of either marker in normal tissues. The necrotic fraction determined in tumours did not correlate with the tumour volume or with the tumour-to-muscle radioactivity uptake ratio. This study shows that the uptake of both [18F]FETNIM and [18F]FMISO correlates with the oxygenation status in tumours. In addition, our data show no significant difference in the intratumoral uptake between the two markers. However, significantly higher radioactivity uptake values were measured for [18F]FMISO than for [18F]FETNIM in normal tissues.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14722675     DOI: 10.1007/s00259-003-1404-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  38 in total

1.  Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole.

Authors:  W J Koh; J S Rasey; M L Evans; J R Grierson; T K Lewellen; M M Graham; K A Krohn; T W Griffin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

2.  Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratio.

Authors:  Kaisa Lehtiö; Vesa Oikonen; Samuel Nyman; Tove Grönroos; Anne Roivainen; Olli Eskola; Heikki Minn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-10-30       Impact factor: 9.236

Review 3.  Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays.

Authors:  J D Chapman; E L Engelhardt; C C Stobbe; R F Schneider; G E Hanks
Journal:  Radiother Oncol       Date:  1998-03       Impact factor: 6.280

4.  Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients.

Authors:  J S Rasey; W J Koh; M L Evans; L M Peterson; T K Lewellen; M M Graham; K A Krohn
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-09-01       Impact factor: 7.038

5.  A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy.

Authors:  M Nordsmark; J Overgaard
Journal:  Radiother Oncol       Date:  2000-10       Impact factor: 6.280

6.  Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data.

Authors:  J E Moulder; S Rockwell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-05       Impact factor: 7.038

Review 7.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

Authors:  P Vaupel; F Kallinowski; P Okunieff
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

8.  Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volume and carbogen breathing.

Authors:  Lise Bentzen; Susanne Keiding; Michael R Horsman; Tove Grönroos; Søren B Hansen; Jens Overgaard
Journal:  Acta Oncol       Date:  2002       Impact factor: 4.089

9.  Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation.

Authors:  M R Horsman; A A Khalil; D W Siemann; C Grau; S A Hill; E M Lynch; D J Chaplin; J Overgaard
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-06-15       Impact factor: 7.038

10.  A marker for hypoxic cells in tumours with potential clinical applicability.

Authors:  J D Chapman; A J Franko; J Sharplin
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640

View more
  26 in total

1.  Imaging of tumour hypoxia using PET and 18F-labelled tracers: biology meets technology.

Authors:  Tove Grönroos; Heikki Minn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10       Impact factor: 9.236

2.  To Explore a Representative Hypoxic Parameter to Predict the Treatment Response and Prognosis Obtained by [18F]FMISO-PET in Patients with Non-small Cell Lung Cancer.

Authors:  Li Li; Yuchun Wei; Yong Huang; Qingxi Yu; Wenju Liu; Shuqiang Zhao; Jinsong Zheng; Hong Lu; Jinming Yu; Shuanghu Yuan
Journal:  Mol Imaging Biol       Date:  2018-12       Impact factor: 3.488

3.  Correlation of hypoxia as measured by fluorine-18 fluoroerythronitroimidazole (18F-FETNIM) PET/CT and overall survival in glioma patients.

Authors:  Man Hu; Yufang Zhu; Dianbin Mu; Bingjie Fan; Shuqiang Zhao; Guoren Yang; Li Ma; Jinsong Zheng; Jinming Yu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-28       Impact factor: 9.236

4.  NanoPET imaging of [(18)F]fluoromisonidazole uptake in experimental mouse tumours.

Authors:  Matthias T Wyss; Michael Honer; Pius A Schubiger; Simon M Ametamey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-29       Impact factor: 9.236

5.  The radiation response of cells from 9L gliosarcoma tumours is correlated with [F18]-EF5 uptake.

Authors:  Cameron J Koch; Anne L Shuman; Walter T Jenkins; Alexander V Kachur; Joel S Karp; Richard Freifelder; William R Dolbier; Sydney M Evans
Journal:  Int J Radiat Biol       Date:  2009-12       Impact factor: 2.694

Review 6.  Positron emission tomography to assess hypoxia and perfusion in lung cancer.

Authors:  Eline E Verwer; Ronald Boellaard; Astrid Am van der Veldt
Journal:  World J Clin Oncol       Date:  2014-12-10

Review 7.  Contribution of hypoxia-measuring molecular imaging techniques to radiotherapy planning and treatment.

Authors:  Carlos Ferrer Albiach; Antonio Conde Moreno; Marta Rodríguez Cordón; Virginia Morillo Macías; Ana Bouché Babiloni; Inmaculada Beato Tortajada; Angel Sánchez Iglesias; Alicia Francés Muñoz
Journal:  Clin Transl Oncol       Date:  2010-01       Impact factor: 3.405

Review 8.  Molecular imaging of hypoxia with radiolabelled agents.

Authors:  Gilles Mees; Rudi Dierckx; Christel Vangestel; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-06-30       Impact factor: 9.236

9.  Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts.

Authors:  Johanna Tuomela; Tove J Grönroos; Maija P Valta; Jouko Sandholm; Aleksi Schrey; Jani Seppänen; Päivi Marjamäki; Sarita Forsback; Ilpo Kinnunen; Olof Solin; Heikki Minn; Pirkko L Härkönen
Journal:  BMC Cancer       Date:  2010-10-30       Impact factor: 4.430

10.  [18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model.

Authors:  Ludwig Dubois; Willy Landuyt; Lieselotte Cloetens; Anne Bol; Guy Bormans; Karin Haustermans; Daniel Labar; Johan Nuyts; Vincent Grégoire; Luc Mortelmans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-09       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.